Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials

Due to large homology of human and canine EGFR, dogs suffering from spontaneous EGFR+ cancer can be considered as ideal translational models. Thereby, novel immunotherapeutic compounds can be developed for both human and veterinary patients. This study describes the radiolabeling of a canine anti-EG...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazekas-Singer, Judit, Berroterán-Infante, Neydher, Rami-Mark, Christina, Dumanic, Monika, Matz, Miroslawa, Willmann, Michael, Andreae, Fritz, Singer, Josef, Wadsak, Wolfgang, Mitterhauser, Markus, Jensen-Jarolim, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669955/
https://www.ncbi.nlm.nih.gov/pubmed/29137329
http://dx.doi.org/10.18632/oncotarget.20914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669955/
https://www.ncbi.nlm.nih.gov/pubmed/29137329
http://dx.doi.org/10.18632/oncotarget.20914

Ejemplares similares